Nymox Pharmaceutical
NYMX
#10169
Rank
โ‚น1.66 B
Marketcap
Country
โ‚น18.21
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): -โ‚น4.92

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -โ‚น5.46. In 2022 the company made an earnings per share (EPS) of -โ‚น7.28 an increase over its 2021 EPS that were of -โ‚น13.66.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น4.92-32.46%
2022-โ‚น7.28-46.67%
2021-โ‚น13.66-11.76%
2020-โ‚น15.48-15%
2019-โ‚น18.215.26%
2018-โ‚น17.30-26.92%
2017-โ‚น23.67-7.14%
2016-โ‚น25.49-40.43%
2015-โ‚น42.79291.67%
2014-โ‚น10.92-7.69%
2013-โ‚น11.84-43.48%
2012-โ‚น20.94-25.81%
2011-โ‚น28.2255%
2010-โ‚น18.2125%
2009-โ‚น14.570.08%
2008-โ‚น14.55-11.12%
2007-โ‚น16.38-0.16%
2006-โ‚น16.4028.59%
2005-โ‚น12.76-12.49%
2004-โ‚น14.58-16.05%
2003-โ‚น17.3619.07%
2002-โ‚น14.5814.45%
2001-โ‚น12.74-22.16%
2000-โ‚น16.375.64%
1999-โ‚น15.49-34.59%
1998-โ‚น23.69-3.6%
1997-โ‚น24.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,014-18,662.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น123.81-2,366.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น341.30-6,348.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,096-38,466.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น786.59-14,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA